Cargando…

HMCDA: a novel method based on the heterogeneous graph neural network and metapath for circRNA-disease associations prediction

Circular RNA (CircRNA) is a type of non-coding RNAs in which both ends are covalently linked. Researchers have demonstrated that many circRNAs can act as biomarkers of diseases. However, traditional experimental methods for circRNA-disease associations identification are labor-intensive. In this wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Shiyang, Liu, Siwei, Song, Junliang, Lin, Qiang, Zhao, Shihong, Li, Shuaixin, Li, Jiahui, Liang, Shangsong, Wang, Jingjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494331/
https://www.ncbi.nlm.nih.gov/pubmed/37697297
http://dx.doi.org/10.1186/s12859-023-05441-7
_version_ 1785104667420655616
author Liang, Shiyang
Liu, Siwei
Song, Junliang
Lin, Qiang
Zhao, Shihong
Li, Shuaixin
Li, Jiahui
Liang, Shangsong
Wang, Jingjie
author_facet Liang, Shiyang
Liu, Siwei
Song, Junliang
Lin, Qiang
Zhao, Shihong
Li, Shuaixin
Li, Jiahui
Liang, Shangsong
Wang, Jingjie
author_sort Liang, Shiyang
collection PubMed
description Circular RNA (CircRNA) is a type of non-coding RNAs in which both ends are covalently linked. Researchers have demonstrated that many circRNAs can act as biomarkers of diseases. However, traditional experimental methods for circRNA-disease associations identification are labor-intensive. In this work, we propose a novel method based on the heterogeneous graph neural network and metapaths for circRNA-disease associations prediction termed as HMCDA. First, a heterogeneous graph consisting of circRNA-disease associations, circRNA-miRNA associations, miRNA-disease associations and disease-disease associations are constructed. Then, six metapaths are defined and generated according to the biomedical pathways. Afterwards, the entity content transformation, intra-metapath and inter-metapath aggregation are implemented to learn the embeddings of circRNA and disease entities. Finally, the learned embeddings are used to predict novel circRNA-disase associations. In particular, the result of extensive experiments demonstrates that HMCDA outperforms four state-of-the-art models in fivefold cross validation. In addition, our case study indicates that HMCDA has the ability to identify novel circRNA-disease associations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-023-05441-7.
format Online
Article
Text
id pubmed-10494331
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104943312023-09-12 HMCDA: a novel method based on the heterogeneous graph neural network and metapath for circRNA-disease associations prediction Liang, Shiyang Liu, Siwei Song, Junliang Lin, Qiang Zhao, Shihong Li, Shuaixin Li, Jiahui Liang, Shangsong Wang, Jingjie BMC Bioinformatics Research Circular RNA (CircRNA) is a type of non-coding RNAs in which both ends are covalently linked. Researchers have demonstrated that many circRNAs can act as biomarkers of diseases. However, traditional experimental methods for circRNA-disease associations identification are labor-intensive. In this work, we propose a novel method based on the heterogeneous graph neural network and metapaths for circRNA-disease associations prediction termed as HMCDA. First, a heterogeneous graph consisting of circRNA-disease associations, circRNA-miRNA associations, miRNA-disease associations and disease-disease associations are constructed. Then, six metapaths are defined and generated according to the biomedical pathways. Afterwards, the entity content transformation, intra-metapath and inter-metapath aggregation are implemented to learn the embeddings of circRNA and disease entities. Finally, the learned embeddings are used to predict novel circRNA-disase associations. In particular, the result of extensive experiments demonstrates that HMCDA outperforms four state-of-the-art models in fivefold cross validation. In addition, our case study indicates that HMCDA has the ability to identify novel circRNA-disease associations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-023-05441-7. BioMed Central 2023-09-11 /pmc/articles/PMC10494331/ /pubmed/37697297 http://dx.doi.org/10.1186/s12859-023-05441-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liang, Shiyang
Liu, Siwei
Song, Junliang
Lin, Qiang
Zhao, Shihong
Li, Shuaixin
Li, Jiahui
Liang, Shangsong
Wang, Jingjie
HMCDA: a novel method based on the heterogeneous graph neural network and metapath for circRNA-disease associations prediction
title HMCDA: a novel method based on the heterogeneous graph neural network and metapath for circRNA-disease associations prediction
title_full HMCDA: a novel method based on the heterogeneous graph neural network and metapath for circRNA-disease associations prediction
title_fullStr HMCDA: a novel method based on the heterogeneous graph neural network and metapath for circRNA-disease associations prediction
title_full_unstemmed HMCDA: a novel method based on the heterogeneous graph neural network and metapath for circRNA-disease associations prediction
title_short HMCDA: a novel method based on the heterogeneous graph neural network and metapath for circRNA-disease associations prediction
title_sort hmcda: a novel method based on the heterogeneous graph neural network and metapath for circrna-disease associations prediction
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494331/
https://www.ncbi.nlm.nih.gov/pubmed/37697297
http://dx.doi.org/10.1186/s12859-023-05441-7
work_keys_str_mv AT liangshiyang hmcdaanovelmethodbasedontheheterogeneousgraphneuralnetworkandmetapathforcircrnadiseaseassociationsprediction
AT liusiwei hmcdaanovelmethodbasedontheheterogeneousgraphneuralnetworkandmetapathforcircrnadiseaseassociationsprediction
AT songjunliang hmcdaanovelmethodbasedontheheterogeneousgraphneuralnetworkandmetapathforcircrnadiseaseassociationsprediction
AT linqiang hmcdaanovelmethodbasedontheheterogeneousgraphneuralnetworkandmetapathforcircrnadiseaseassociationsprediction
AT zhaoshihong hmcdaanovelmethodbasedontheheterogeneousgraphneuralnetworkandmetapathforcircrnadiseaseassociationsprediction
AT lishuaixin hmcdaanovelmethodbasedontheheterogeneousgraphneuralnetworkandmetapathforcircrnadiseaseassociationsprediction
AT lijiahui hmcdaanovelmethodbasedontheheterogeneousgraphneuralnetworkandmetapathforcircrnadiseaseassociationsprediction
AT liangshangsong hmcdaanovelmethodbasedontheheterogeneousgraphneuralnetworkandmetapathforcircrnadiseaseassociationsprediction
AT wangjingjie hmcdaanovelmethodbasedontheheterogeneousgraphneuralnetworkandmetapathforcircrnadiseaseassociationsprediction